38,000 Shares in Scholar Rock Holding Co. (NASDAQ:SRRK) Acquired by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale acquired a new stake in Scholar Rock Holding Co. (NASDAQ:SRRK) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 38,000 shares of the company’s stock, valued at approximately $768,000.

Several other institutional investors have also recently bought and sold shares of the business. Legal & General Group Plc raised its position in Scholar Rock by 8.1% in the 4th quarter. Legal & General Group Plc now owns 14,265 shares of the company’s stock valued at $129,000 after purchasing an additional 1,072 shares during the last quarter. Amalgamated Bank raised its position in Scholar Rock by 52.8% in the 3rd quarter. Amalgamated Bank now owns 4,217 shares of the company’s stock valued at $30,000 after purchasing an additional 1,458 shares during the last quarter. Alps Advisors Inc. increased its stake in shares of Scholar Rock by 4.1% in the 3rd quarter. Alps Advisors Inc. now owns 41,535 shares of the company’s stock valued at $295,000 after buying an additional 1,628 shares during the period. California State Teachers Retirement System increased its stake in shares of Scholar Rock by 4.2% in the 3rd quarter. California State Teachers Retirement System now owns 43,175 shares of the company’s stock valued at $307,000 after buying an additional 1,730 shares during the period. Finally, Rhumbline Advisers increased its stake in shares of Scholar Rock by 7.0% in the 1st quarter. Rhumbline Advisers now owns 29,405 shares of the company’s stock valued at $379,000 after buying an additional 1,918 shares during the period. Institutional investors own 91.08% of the company’s stock.

Analysts Set New Price Targets

SRRK has been the subject of several research reports. Wedbush reissued an “outperform” rating and issued a $23.00 target price on shares of Scholar Rock in a research note on Tuesday, January 23rd. Piper Sandler reissued an “overweight” rating and issued a $28.00 target price on shares of Scholar Rock in a research note on Tuesday, March 26th. HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Scholar Rock in a research note on Tuesday, March 19th. Raymond James initiated coverage on Scholar Rock in a research note on Thursday, March 28th. They issued a “strong-buy” rating and a $30.00 target price for the company. Finally, Truist Financial reissued a “buy” rating and issued a $20.00 target price on shares of Scholar Rock in a research note on Wednesday, April 3rd. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Scholar Rock presently has an average rating of “Buy” and an average price target of $25.17.

Scholar Rock Stock Down 0.9 %

Shares of Scholar Rock stock opened at $13.33 on Tuesday. Scholar Rock Holding Co. has a 12 month low of $5.56 and a 12 month high of $21.17. The stock has a market cap of $1.04 billion, a PE ratio of -6.70 and a beta of 0.90. The company has a quick ratio of 8.80, a current ratio of 8.80 and a debt-to-equity ratio of 0.22. The business has a fifty day simple moving average of $15.59 and a 200 day simple moving average of $14.16.

Scholar Rock (NASDAQ:SRRK) last released its earnings results on Tuesday, March 19th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Research analysts predict that Scholar Rock Holding Co. will post -2.01 EPS for the current year.

Insider Buying and Selling

In related news, CFO Edward H. Myles sold 4,744 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $15.74, for a total transaction of $74,670.56. Following the sale, the chief financial officer now owns 210,976 shares in the company, valued at $3,320,762.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Scholar Rock news, CFO Edward H. Myles sold 4,744 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total transaction of $74,670.56. Following the transaction, the chief financial officer now owns 210,976 shares of the company’s stock, valued at $3,320,762.24. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, General Counsel Junlin Ho sold 3,489 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total value of $54,916.86. Following the transaction, the general counsel now directly owns 208,771 shares in the company, valued at approximately $3,286,055.54. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,359 shares of company stock worth $351,931. Corporate insiders own 26.20% of the company’s stock.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.